3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Sarcoma
210
Bone Neoplasms
58
Neoplasms
39
Breast Neoplasms
39
Osteosarcoma
37
Lymphoma
34
Precursor Cell Lymphoblastic Leukemia-Lymphoma
31
Gastrointestinal Stromal Tumors
31
Dendritic Cell Sarcoma, Interdigitating
31
Hodgkin Disease
29
Lymphoma, Non-Hodgkin
27
Leukemia
27
Burkitt Lymphoma
25
Melanoma
24
Brain Neoplasms
24
Multiple Myeloma
23
Leukemia, Myeloid, Acute
23
Sarcoma, Ewing
22
Recurrence
21
Lymphoma, Mantle-Cell
21
Lymphoma, Large B-Cell, Diffuse
21
Glioblastoma
21
Neuroblastoma
20
Lymphoma, Follicular
20
Leukemia, Lymphocytic, Chronic, B-Cell
20
Lymphoma, Large-Cell, Immunoblastic
18
Gliosarcoma
18
Sarcoma, Kaposi
17
Prostatic Neoplasms
17
Pancreatic Neoplasms
17
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Fractures, Bone
×
Sarcoma
×
Clear all
NCT06376682
2025-09-22
EPIBONE
Precision IO Group
Phase NA
Completed
34 enrolled
11 charts